» Articles » PMID: 39917063

Inflammatory Lipid Biomarkers and Transplant-free Mortality Risk in Hepatitis B-related Cirrhosis and Hepatic Encephalopathy

Overview
Date 2025 Feb 7
PMID 39917063
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Inflammatory reactions and dyslipidemia are associated with the pathogenesis and prognosis of hepatitis B virus-related cirrhosis. We aimed to assess the predictive ability of these parameters in patients with hepatitis B virus-related cirrhosis and overt hepatic encephalopathy (HBV-related OHE).

Design: We conducted an analysis of 1,404 participants diagnosed with HBV-related OHE between January 2008 and July 2023. The prognostic significance of the neutrophil-to-high-density lipoprotein cholesterol (HDL-C) ratio (NHR), lymphocyte-to-HDL-C ratio (LHR), and monocyte-to-HDL-C ratio (MHR) was evaluated using the area under the receiver operating characteristic curve (AUC). Restrictive cubic splines (RCS) were employed to explore the relationship between NHR and 12-month transplant-free (TF) mortality. This study included a prospective test cohort of 328 patients.

Results: NHR was identified as an independent risk factor for 12-month TF mortality. The AUC for NHR (0.776) was similar to that of the model end-stage liver disease (MELD) score (AUC: 0.777). In the test cohort, NHR demonstrated AUC values comparable to MELD, with significantly higher AUCs than LHR and MHR (both  < 0.05). Based on cutoff values for NHR and MELD, patients were classified into four risk subgroups: very-low (NHR < 10 and MELD <18), low (NHR ≥ 10 and MELD <18), moderate (NHR < 10 and MELD ≥18), and high (NHR ≥ 10 and MELD ≥18). The 12-month TF mortality rates in the training cohort were 7.2, 23.5, 30.8, and 51.4%, respectively, for these subgroups, while in the test cohort, the rates were 8.7, 20.5, 30.7, and 46.0%.

Conclusion: NHR is a valuable and accessible prognostic indicator for 12-month TF mortality in patients with HBV-related OHE. Patients with both NHR ≥ 10 and MELD ≥18 are at the highest risk of mortality.

References
1.
Lopez-Vicario C, Checa A, Urdangarin A, Aguilar F, Alcaraz-Quiles J, Caraceni P . Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis. J Hepatol. 2020; 73(4):817-828. DOI: 10.1016/j.jhep.2020.03.046. View

2.
Wang W, Li L, Gu H, Chen Y, Zhen Y, Dong Z . Random Forest-Based Prediction of Acute Respiratory Distress Syndrome in Patients Undergoing Cardiac Surgery. Heart Surg Forum. 2023; 25(6):E854-E859. DOI: 10.1532/hsf.5113. View

3.
Shawcross D, Sharifi Y, Canavan J, Yeoman A, Abeles R, Taylor N . Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol. 2010; 54(4):640-9. DOI: 10.1016/j.jhep.2010.07.045. View

4.
Jiang L, Zhong Z, Huang J, Bian H, Huang W . Monocytohigh-density lipoprotein ratio has a high predictive value for the diagnosis of multiple system atrophy and the differentiation from Parkinson's disease. Front Aging Neurosci. 2022; 14:1035437. PMC: 9607904. DOI: 10.3389/fnagi.2022.1035437. View

5.
Engelmann C, Claria J, Szabo G, Bosch J, Bernardi M . Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021; 75 Suppl 1:S49-S66. PMC: 9272511. DOI: 10.1016/j.jhep.2021.01.002. View